{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:19:39Z","timestamp":1782602379972,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12944-015-0153-8","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T11:58:38Z","timestamp":1448452718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Discordant associations of lipid parameters with albuminuria and chronic kidney disease: a population-based study"],"prefix":"10.1186","volume":"14","author":[{"given":"Kan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diaozhu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chulin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengneng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,25]]},"reference":[{"issue":"13","key":"153_CR1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296\u2013305.","journal-title":"N Engl J Med"},{"issue":"9818","key":"153_CR2","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","volume":"379","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815\u201322.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"153_CR3","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.2337\/dc14-S014","volume":"37","author":"American Diabetes Association","year":"2014","unstructured":"American Diabetes Association. Standards of medical care in diabetes--2014. Diabetes Care. 2014;37 Suppl 1:S14\u201380.","journal-title":"Diabetes Care"},{"issue":"8","key":"153_CR4","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/01.CIR.0000139860.33974.28","volume":"110","author":"D Zeeuw de","year":"2004","unstructured":"de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation. 2004;110(8):921\u20137.","journal-title":"Circulation"},{"issue":"4","key":"153_CR5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00285287","volume":"32","author":"T Deckert","year":"1989","unstructured":"Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia. 1989;32(4):219\u201326.","journal-title":"Diabetologia"},{"issue":"4","key":"153_CR6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","volume":"286","author":"HC Gerstein","year":"2001","unstructured":"Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286(4):421\u20136.","journal-title":"JAMA"},{"issue":"1","key":"153_CR7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/CIRCULATIONAHA.113.003429","volume":"129","author":"DH Katz","year":"2014","unstructured":"Katz DH, Selvaraj S, Aguilar FG, Martinez EE, Beussink L, Kim KY, et al. Association of low-grade albuminuria with adverse cardiac mechanics: findings from the hypertension genetic epidemiology network (HyperGEN) study. Circulation. 2014;129(1):42\u201350.","journal-title":"Circulation"},{"issue":"7","key":"153_CR8","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/CIRCULATIONAHA.105.538132","volume":"112","author":"J Arnlov","year":"2005","unstructured":"Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005;112(7):969\u201375.","journal-title":"Circulation"},{"issue":"14","key":"153_CR9","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/eurheartj\/ehm130","volume":"28","author":"E Ingelsson","year":"2007","unstructured":"Ingelsson E, Sundstrom J, Lind L, Riserus U, Larsson A, Basu S, et al. Low-grade albuminuria and the incidence of heart failure in a community-based cohort of elderly men. Eur Heart J. 2007;28(14):1739\u201345.","journal-title":"Eur Heart J"},{"issue":"4","key":"153_CR10","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","volume":"121","author":"DM Lloyd-Jones","year":"2010","unstructured":"Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation. 2010;121(4):586\u2013613.","journal-title":"Circulation"},{"issue":"4","key":"153_CR11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7326\/0003-4819-157-4-201208210-00005","volume":"157","author":"A Upadhyay","year":"2012","unstructured":"Upadhyay A, Earley A, Lamont JL, Haynes S, Wanner C, Balk EM. Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med. 2012;157(4):251\u201362.","journal-title":"Ann Intern Med"},{"issue":"1","key":"153_CR12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2215\/CJN.03390807","volume":"3","author":"IH Boer de","year":"2008","unstructured":"de Boer IH, Astor BC, Kramer H, Palmas W, Seliger SL, Shlipak MG, et al. Lipoprotein abnormalities associated with mild impairment of kidney function in the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol. 2008;3(1):125\u201332.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"153_CR13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1523-1755.2005.00406.x","volume":"68","author":"PA Kalra","year":"2005","unstructured":"Kalra PA, Guo H, Kausz AT, Gilbertson DT, Liu J, Chen SC, et al. Atherosclerotic renovascular disease in United States patients aged 67\u00a0years or older: risk factors, revascularization, and prognosis. Kidney Int. 2005;68(1):293\u2013301.","journal-title":"Kidney Int"},{"issue":"8","key":"153_CR14","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S2213-8587(14)70102-0","volume":"2","author":"Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration","year":"2014","unstructured":"Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2014;2(8):634\u201347.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"153_CR15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S2213-8587(14)70162-7","volume":"2","author":"B Bikbov","year":"2014","unstructured":"Bikbov B, Perico N, Remuzzi G. High serum cholesterol: a missed risk factor for chronic kidney disease mortality. Lancet Diabetes Endocrinol. 2014;2(8):613\u20134.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"153_CR16","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1001\/jama.2012.366","volume":"307","author":"SM Boekholdt","year":"2012","unstructured":"Boekholdt SM, Arsenault BJ, Mora S, Pedersen TR, LaRosa JC, Nestel PJ, et al. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. JAMA. 2012;307(12):1302\u20139.","journal-title":"JAMA"},{"issue":"7","key":"153_CR17","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.2337\/diacare.28.7.1796","volume":"28","author":"RR Holman","year":"2005","unstructured":"Holman RR, Coleman RL, Shine BS, Stevens RJ. Non-HDL cholesterol is less informative than the total-to-HDL cholesterol ratio in predicting cardiovascular risk in type 2 diabetes. Diabetes Care. 2005;28(7):1796\u20137.","journal-title":"Diabetes Care"},{"issue":"2","key":"153_CR18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/1753-0407.12108","volume":"6","author":"Y Bi","year":"2014","unstructured":"Bi Y, Lu J, Wang W, Mu Y, Zhao J, Liu C, et al. Cohort profile: risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study. J Diabetes. 2014;6(2):147\u201357.","journal-title":"J Diabetes"},{"issue":"2","key":"153_CR19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1753-0407.2012.00182.x","volume":"4","author":"G Ning","year":"2012","unstructured":"Ning G. Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. J Diabetes. 2012;4(2):172\u20133.","journal-title":"J Diabetes"},{"issue":"10","key":"153_CR20","doi-asserted-by":"crossref","first-page":"e47791","DOI":"10.1371\/journal.pone.0047791","volume":"7","author":"K Sun","year":"2012","unstructured":"Sun K, Liu J, Ning G. Active smoking and risk of metabolic syndrome: a meta-analysis of prospective studies. PLoS One. 2012;7(10):e47791.","journal-title":"PLoS One"},{"issue":"6","key":"153_CR21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2188\/jea.JE20110003","volume":"21","author":"K Tomioka","year":"2011","unstructured":"Tomioka K, Iwamoto J, Saeki K, Okamoto N. Reliability and validity of the International Physical Activity Questionnaire (IPAQ) in elderly adults: the Fujiwara-kyo Study. J Epidemiol. 2011;21(6):459\u201365.","journal-title":"J Epidemiol"},{"issue":"3","key":"153_CR22","first-page":"245","volume":"15","author":"BF Zhou","year":"2002","unstructured":"Zhou BF. Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases--report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomed Environ Sci. 2002;15(3):245\u201352.","journal-title":"Biomed Environ Sci"},{"issue":"19","key":"153_CR23","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486\u201397.","journal-title":"JAMA"},{"issue":"12","key":"153_CR24","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2337\/diacare.21.12.2191","volume":"21","author":"JC Levy","year":"1998","unstructured":"Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21(12):2191\u20132.","journal-title":"Diabetes Care"},{"issue":"7","key":"153_CR25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia"},{"issue":"10","key":"153_CR26","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1681\/ASN.2006040368","volume":"17","author":"YC Ma","year":"2006","unstructured":"Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937\u201344.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"153_CR27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1523-1755.2000.00165.x","volume":"58","author":"P Muntner","year":"2000","unstructured":"Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int. 2000;58(1):293\u2013301.","journal-title":"Kidney Int"},{"issue":"1\u20132","key":"153_CR28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.cca.2011.10.021","volume":"413","author":"HT Kang","year":"2012","unstructured":"Kang HT, Kim JK, Kim JY, Linton JA, Yoon JH, Koh SB. Independent association of TG\/HDL-C with urinary albumin excretion in normotensive subjects in a rural Korean population. Clin Chim Acta. 2012;413(1\u20132):319\u201324.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"153_CR29","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.atherosclerosis.2013.12.037","volume":"233","author":"K Tsuruya","year":"2014","unstructured":"Tsuruya K, Yoshida H, Nagata M, Kitazono T, Hirakata H, Iseki K, et al. Association of the triglycerides to high-density lipoprotein cholesterol ratio with the risk of chronic kidney disease: analysis in a large Japanese population. Atherosclerosis. 2014;233(1):260\u20137.","journal-title":"Atherosclerosis"},{"issue":"3","key":"153_CR30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000323895","volume":"34","author":"HT Kang","year":"2011","unstructured":"Kang HT, Shim JY, Lee YJ, Lee JE, Linton JA, Kim JK, et al. Association between the ratio of triglycerides to high-density lipoprotein cholesterol and chronic kidney disease in Korean adults: the 2005 Korean National Health and Nutrition Examination Survey. Kidney Blood Press Res. 2011;34(3):173\u20139.","journal-title":"Kidney Blood Press Res"},{"issue":"6","key":"153_CR31","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.numecd.2015.03.003","volume":"25","author":"PY Zuo","year":"2015","unstructured":"Zuo PY, Chen XL, Liu YW, Zhang R, He XX, Liu CY. Non-HDL-cholesterol to HDL-cholesterol ratio as an independent risk factor for the development of chronic kidney disease. Nutr Metab Cardiovasc Dis. 2015;25(6):582\u20137.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"6","key":"153_CR32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/hr.2010.39","volume":"33","author":"NJ Heo","year":"2010","unstructured":"Heo NJ, Ahn JM, Lee TW, Chin HJ, Na KY, Chae DW, et al. Very low-grade albuminuria reflects susceptibility to chronic kidney disease in combination with cardiovascular risk factors. Hypertens Res. 2010;33(6):573\u20138.","journal-title":"Hypertens Res"},{"issue":"1","key":"153_CR33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.CIR.0000133312.96477.48","volume":"110","author":"K Klausen","year":"2004","unstructured":"Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation. 2004;110(1):32\u20135.","journal-title":"Circulation"},{"issue":"3","key":"153_CR34","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/joim.12081","volume":"274","author":"A Baragetti","year":"2013","unstructured":"Baragetti A, Norata GD, Sarcina C, Rastelli F, Grigore L, Garlaschelli K, et al. High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease. J Intern Med. 2013;274(3):252\u201362.","journal-title":"J Intern Med"},{"issue":"6","key":"153_CR35","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1111\/j.1523-1755.2005.00325.x","volume":"67","author":"AC Johnson","year":"2005","unstructured":"Johnson AC, Stahl A, Zager RA. Triglyceride accumulation in injured renal tubular cells: alterations in both synthetic and catabolic pathways. Kidney Int. 2005;67(6):2196\u2013209.","journal-title":"Kidney Int"},{"issue":"6","key":"153_CR36","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1525-139X.2009.00661.x","volume":"22","author":"ND Vaziri","year":"2009","unstructured":"Vaziri ND. Causes of dysregulation of lipid metabolism in chronic renal failure. Semin Dial. 2009;22(6):644\u201351.","journal-title":"Semin Dial"},{"issue":"1","key":"153_CR37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/gfs290","volume":"28","author":"S Cosmo De","year":"2013","unstructured":"De Cosmo S, Menzaghi C, Prudente S, Trischitta V. Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence. Nephrol Dial Transplant. 2013;28(1):29\u201336.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"153_CR38","doi-asserted-by":"crossref","first-page":"802","DOI":"10.7326\/0003-4819-139-10-200311180-00007","volume":"139","author":"T McLaughlin","year":"2003","unstructured":"McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003;139(10):802\u20139.","journal-title":"Ann Intern Med"},{"issue":"4","key":"153_CR39","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/01.HYP.35.4.898","volume":"35","author":"JS Jensen","year":"2000","unstructured":"Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension. 2000;35(4):898\u2013903.","journal-title":"Hypertension"},{"issue":"2","key":"153_CR40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2337\/diacare.22.2.307","volume":"22","author":"AJ Bakker","year":"1999","unstructured":"Bakker AJ. Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration. Diabetes Care. 1999;22(2):307\u201313.","journal-title":"Diabetes Care"},{"issue":"4","key":"153_CR41","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0272-6386(03)00826-6","volume":"42","author":"G Eknoyan","year":"2003","unstructured":"Eknoyan G, Hostetter T, Bakris GL, Hebert L, Levey AS, Parving HH, et al. Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis. 2003;42(4):617\u201322.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"153_CR42","volume":"10","author":"MA Salinero-Fort","year":"2015","unstructured":"Salinero-Fort MA, San Andres-Rebollo FJ, de Burgos-Lunar C, Gomez-Campelo P, Chico-Moraleja RM, Lopez de Andres A, et al. Five-year incidence of chronic kidney disease (stage 3\u20135) and associated risk factors in a Spanish cohort: the MADIABETES Study. PLoS One. 2015;10(4), e0122030.","journal-title":"PLoS One"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-015-0153-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T20:24:20Z","timestamp":1498249460000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.lipidworld.com\/content\/14\/1\/152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,25]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["153"],"URL":"https:\/\/doi.org\/10.1186\/s12944-015-0153-8","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,25]]},"article-number":"152"}}